Literature DB >> 27974456

Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption.

Sandra E Dross1,2, Paul V Munson3,4, Se Eun Kim2, Debra L Bratt4, Hillary C Tunggal3,4, Ana L Gervassi2, Deborah H Fuller3,4, Helen Horton5,6.   

Abstract

During chronic lentiviral infection, poor clinical outcomes correlate both with systemic inflammation and poor proliferative ability of HIV-specific T cells; however, the connection between the two is not clear. Myeloid-derived suppressor cells (MDSC), which expand during states of elevated circulating inflammatory cytokines, may link the systemic inflammation and poor T cell function characteristic of lentiviral infections. Although MDSC are partially characterized in HIV and SIV infection, questions remain regarding their persistence, activity, and clinical significance. We monitored MDSC frequency and function in SIV-infected rhesus macaques. Low MDSC frequency was observed prior to SIV infection. Post-SIV infection, MDSC were elevated in acute infection and persisted during 7 mo of combination antiretroviral drug therapy (cART). After cART interruption, we observed MDSC expansion of surprising magnitude, the majority being granulocytic MDSC. At all stages of infection, granulocytic MDSC suppressed CD4+ and CD8+ T cell proliferation in response to polyclonal or SIV-specific stimulation. In addition, MDSC frequency correlated significantly with circulating inflammatory cytokines. Acute and post-cART levels of viremia were similar, however, the levels of inflammatory cytokines and MDSC were more pronounced post-cART. Expanded MDSC during SIV infection, especially during the post-cART inflammatory cytokine surge, likely limit cellular responses to infection. As many HIV curative strategies require cART interruption to determine efficacy, our work suggests treatment interruption-induced MDSC may especially undermine the effectiveness of such strategies. MDSC depletion may enhance T cell responses to lentiviral infection and the effectiveness of curative approaches.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27974456      PMCID: PMC5225043          DOI: 10.4049/jimmunol.1600759

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection.

Authors:  Lucio Gama; Erin N Shirk; Julia N Russell; Karina I Carvalho; Ming Li; Suzanne E Queen; Jorge Kalil; M Christine Zink; Janice E Clements; Esper G Kallas
Journal:  J Leukoc Biol       Date:  2012-02-24       Impact factor: 4.962

2.  High-dimensional immunomonitoring models of HIV-1-specific CD8 T-cell responses accurately identify subjects achieving spontaneous viral control.

Authors:  Zaza M Ndhlovu; Lori B Chibnik; Jacqueline Proudfoot; Seanna Vine; Ashley McMullen; Kevin Cesa; Filippos Porichis; R Brad Jones; Donna Marie Alvino; Meghan G Hart; Eleni Stampouloglou; Alicja Piechocka-Trocha; Carl Kadie; Florencia Pereyra; David Heckerman; Philip L De Jager; Bruce D Walker; Daniel E Kaufmann
Journal:  Blood       Date:  2012-12-11       Impact factor: 22.113

3.  Vaccine-induced myeloid cell population dampens protective immunity to SIV.

Authors:  Yongjun Sui; Alison Hogg; Yichuan Wang; Blake Frey; Huifeng Yu; Zheng Xia; David Venzon; Katherine McKinnon; Jeremy Smedley; Mercy Gathuka; Dennis Klinman; Brandon F Keele; Sol Langermann; Linda Liu; Genoveffa Franchini; Jay A Berzofsky
Journal:  J Clin Invest       Date:  2014-05-16       Impact factor: 14.808

4.  Signal transducer and activator of transcription 3 (Stat3C) promotes myeloid-derived suppressor cell expansion and immune suppression during lung tumorigenesis.

Authors:  Lingyan Wu; Hong Du; Yuan Li; Peng Qu; Cong Yan
Journal:  Am J Pathol       Date:  2011-08-22       Impact factor: 4.307

5.  Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Authors:  Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek
Journal:  J Infect Dis       Date:  2011-01-20       Impact factor: 5.226

6.  Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells.

Authors:  Thomas Vollbrecht; Renate Stirner; Amanda Tufman; Julia Roider; Rudolf M Huber; Johannes R Bogner; Andreas Lechner; Carole Bourquin; Rika Draenert
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

7.  Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

Authors:  Athanasios Kotsakis; Malgorzata Harasymczuk; Bastian Schilling; Vasilis Georgoulias; Athanassios Argiris; Theresa L Whiteside
Journal:  J Immunol Methods       Date:  2012-04-13       Impact factor: 2.303

8.  Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.

Authors:  Donald T Weed; Paolo Serafini; Jennifer L Vella; Isildinha M Reis; Adriana C De la Fuente; Carmen Gomez; Zoukaa Sargi; Ronen Nazarian; Joseph Califano; Ivan Borrello
Journal:  Clin Cancer Res       Date:  2014-10-15       Impact factor: 12.531

9.  TNF signaling drives myeloid-derived suppressor cell accumulation.

Authors:  Xueqiang Zhao; Lijie Rong; Xiaopu Zhao; Xiao Li; Xiaoman Liu; Jingjing Deng; Hao Wu; Xia Xu; Ulrike Erben; Peihua Wu; Uta Syrbe; Joachim Sieper; Zhihai Qin
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

10.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Authors:  C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

View more
  8 in total

1.  Early systemic immune biomarkers predict bone regeneration after trauma.

Authors:  Albert Cheng; Casey E Vantucci; Laxminarayanan Krishnan; Marissa A Ruehle; Theresa Kotanchek; Levi B Wood; Krishnendu Roy; Robert E Guldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-23       Impact factor: 11.205

Review 2.  Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections.

Authors:  Anca Dorhoi; Nelita Du Plessis
Journal:  Front Immunol       Date:  2018-01-04       Impact factor: 7.561

Review 3.  Paradoxes in the Phenotype, Frequency and Roles of Myeloid-Derived Suppressor Cells During HIV Infection.

Authors:  Muluneh Ademe
Journal:  HIV AIDS (Auckl)       Date:  2020-04-14

4.  HIV vaccines: Unmasking myeloid derived suppressor cells.

Authors:  William R Green; Megan A O'Connor
Journal:  EBioMedicine       Date:  2020-10-07       Impact factor: 8.143

Review 5.  Neutrophils in COVID-19.

Authors:  Nico Reusch; Elena De Domenico; Lorenzo Bonaguro; Jonas Schulte-Schrepping; Kevin Baßler; Joachim L Schultze; Anna C Aschenbrenner
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

Review 6.  Myeloid-derived suppressor cells and the pathogenesis of human immunodeficiency virus infection.

Authors:  Mahmoud Mohammad Yaseen; Nizar Mohammad Abuharfeil; Homa Darmani
Journal:  Open Biol       Date:  2021-11-10       Impact factor: 6.411

7.  Treatment Intensification in HIV-Infected Patients Is Associated With Reduced Frequencies of Regulatory T Cells.

Authors:  Eva M Grützner; Tanja Hoffmann; Eva Wolf; Elke Gersbacher; Ashley Neizert; Renate Stirner; Ramona Pauli; Albrecht Ulmer; Jürgen Brust; Johannes R Bogner; Hans Jaeger; Rika Draenert
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

8.  Persistent lentivirus infection induces early myeloid suppressor cells expansion to subvert protective memory CD8 T cell response✰,✰✰.

Authors:  Li Liu; Qingqing Lin; Jie Peng; Jun Fang; Zhiwu Tan; Hangying Tang; Kayi Kwan; Kenji Nishiura; Jianguo Liang; Hauyee Kwok; Zhenglong Du; Jiaze Sun; Kang Liu; Kwok-Yung Yuen; Hui Wang; Zhiwei Chen
Journal:  EBioMedicine       Date:  2020-09-24       Impact factor: 8.143

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.